Abstract. The present study investigates the spectrum and incidence of mitochondrial DNA (mtDNA) mutations associated with Leber's hereditary optic neuropathy (LHON) in a Han population using a multi-gene panel with 46 LHON-associated mutations among 13 mitochondrial genes. A total of 23 mutations were observed in a cohort of 275 patients and 281 control subjects using multi-gene panel analysis 
Introduction
Leber's hereditary optic neuropathy (LHON; OMIM 535000) is a classic mitochondrial disease, associated with a rapid, painless, acute or sub-acute bilateral visual loss in young adults, predominantly caused by the primary and secondary mutations in mitochondrial DNA (mtDNA). It has been reported that 1:8,500 individuals harbor a primary LHON-causing mutation and 1:31,000 experience visual loss as a result of LHON in the North East of England (1) . Few significant improvements in visual acuity are reported following atrophy of the optic discs. LHON typically affects males more frequently than females, with the incomplete and variable penetrance estimated at ~50% in males and 10% in females (2) (3) (4) . Additionally, certain LHON cases have additional clinical symptoms, such as movement disorders, dystonia, and multiple-sclerosis-like illness, which complicate the diagnosis in the clinical setting (5) (6) (7) . Although the majority ofcases of LHON transmitted by maternal inheritance have a history of visual loss in families, up to 40% of cases are sporadic (5) .
The genetic cause of LHON is mutations in the mitochondrial genome, which is a double-stranded 16,569-nucleotide pair, circular molecule, consisting of one D-Loop region and 37 genes. The three most causative mutations, m.11778G>A (M T-ND4), m.14484T>C (M T-ND6) and m.3460G>A (MT-ND1), have been reported to account for 90% of LHON patients in a Caucasian population, but for only 38.3 and 46.5% of cases in two large cohorts of Chinese Han subjects with LHON (7) (8) (9) (10) . Our previous studies have shown the spectrum of genes, MT-ND1, MT-ND4 and MT-ND6, and the frequency of the three primary mutations in a Chinese LHON population (8-10) using Sanger sequencing. In addition, secondary mutations that contributed to the high penetrance, including m.3394T>C (MT-ND1), m.11696G>A (MT-ND4), m.12338T>C (MT-ND5) and m.15951A>G (MT-TT) areusually synergized with m.11778G>A or m.14484T>C or m.3460G>A (11 
Materials and methods

DNA samples, extraction, quantification and quality control.
A total of 275 unrelated LHON samples and 281 Chinese control samples were enrolled from the ophthalmology clinics at Zhejiang University School of Medicine (Hangzhou, China) and Wenzhou Medical College (Wenzhou, China) between 2004 and 2015, as described previously (8) (9) (10) 12) , under protocols approved by Zhejiang University and Wenzhou Medical University Ethics Committees. DNA was extracted from 1 ml peripheral blood using a QIAamp DNA Blood Minikit (51106; Qiagen China Co., Ltd., Shanghai, China). The quality and quantity of DNA were assessed using Qubit 3.0 fluorometers (Thermo Fisher Scientific, Inc., Waltham, MA, USA). DNA samples with concentration >1.0 ng/µl were employed in the sequencing experiments.
Multi-genepanel design. Multi-gene target sequencing was performed using the VariantPro™ Capture Technology by LC Sciences (Hangzhou, China) as described previously (13) . The 46 LHON-associated mutations were selected from Mitomap and previous studies (8) (9) (10) . As presented in Table I, they Library preparation and sequencing. Library generation was performed according to the manufacturer's protocol (LC Sciences). Briefly, 5 ng DNA per pool was amplified in 25 cycles of PCR using probe sequences of 27 library amplicons (Table II) and a VariantPro™ PCR mastermix as described previously (13) . PCR runs of 18, 20, 24 and 26 cycles were performed to evaluate the influence of the PCR cycles on the experiment. The correlation coefficient, R 2 , ranged from 0.90-1.00 (average, 0.95), implicating that cycles between 18 and 26 had no influence on the experiment outcome. The amplified products were purified using Agencourt AMPure XP beads [Beckman Coulter (UK) Ltd., High Wycombe, UK]. Each library was diluted to 20 pM and sequenced on an Illumina Miseq with a minimum of 2X 150-bp paired-end reads.
Data analysis. Low quality reads (reads containing sequencing adaptors or nucleotides with quality scores <20) were removed before alignment. Cleaned, paired-end sequence reads in paired FASTQ files were aligned using Burrows-Wheeler Alignment version 0.1.19 (14) . Variant calling was generated using the Genome Analysis Toolkit version 3.3.0 and its Unified Genotyper module (https://www.broadinstitute. org/gatk/guide/tagged?tag=unifiedgenotyper). A Gaussian mixture model was used to evaluate the confidence score for each putative mutation call and novel potential variants. Sequence reads were aligned to the human mtDNA sequence data relative to the revised Cambridge Reference Sequence (GenBank accession no. NC_012920) (15) .
Sanger validation. Thirteen LHON cases associated with m.11778G>A (11) or m.14484T>C (2) mutations and four healthy control samples (available upon request) were selected as the positive and negative controls, respectively, for runs of the panel following validation by Sanger sequencing. Furthermore, 100% correlation was derived from the panel assay and the Sanger sequencing for the positive and negative controls.
Results
Summary of sequencing data.
A total of 118 milion reads were obtained, on average 89% of which were mapped to the amplicon targets and resultedin a mean of 7,001 reads to each sample per amplicon (Table III) . The mean reads over the 27 amplicons were distrubed with an average uniformity of coverage of 98.0% (amplicon mean coverage, 20%) and an average read-depth of 1,000 X (Fig. 1) . A total of 363 variants were distributed in 46 LHON-associated mutations of all samples.
Mutations analysis.
A total of 363 variants were identified in the cohort of all 556 samples; 285 variants were detected in LHON cases as an average incidence of 104%, whereas only 78 variants were identified in 281 controls with a mean incidence of 28% (Table IV) .
As 46 mutations of 13 mitochondrial genes were selected from all populations of the world, variants from LHON cases in the current study were deposited in 8 mitochondrial genes, MT-ND6 for secondary mutations, were 13.45, 4.36 and 4%, respectively. The secondary mutations were predominantly present in the patient and control populations. Of those, mutations m.12338T>C m.4216T>C, m.3571C>T and m.14831 G>A had higher incidences in the control cohort than in the patients. Two LHON-associated mutations (m.14325T>C and m.15812G>A) only arose in the control population in the present study.
MT-ND1, MT-CO3, MT-ND4, MT-ND5, MT-ND6, MT-CYB, MT-TT and MT-TE
1 MT-ND1 3316 3316 G A A-T 2 MT-ND1 3376 3376 G A E-K 3 MT-ND1 3394 3394 T C Y-H 4 MT-ND1 3460 3460 G A A-T 5 MT-ND1 3497 3497 C T A-V 6 MT-ND1 3571 3571 C T L-F 7 MT-ND1 3635 3635 G A S-N 8 MT-ND1 3700 3700 G A A-T 9 MT-ND1 3733 3733 G A E-K 10 MT-ND1 3866 3866 T C I-T 11 MT-ND1 4025 4025 C T T-M 12 MT-ND1 4171 4171 C A L-M 13 MT-ND1 4216 4216 T C Y-H 14 MT-ND2 4640 4640 C A I-M 15 MT-ND2 5244 5244 G A G-S 16 MT-ATP6 9101 9101 T C I-T 17 MT-CO3 9804 9804 G A A-T 18 MT-ND3 10237 10237 T C I-T 19 MT-ND4L 10663 10663 T C V-A 20 MT-ND4L 10680 10680 G A A-T 21 MT-ND4 11253 11253 T C I-T 22 MT-ND4 11696 11696 G A V-I 23 MT-ND4 11778 11778 G A R-H 24 MT-ND5 12338 12338 T C M-T 25 MT-ND5 12811 12811 T C Y-H 26 MT-ND5 12848 12848 C T A-V 27 MT-ND5 13051 13051 G A G-S 28 MT-ND5 13528 13528 A G T-A 29 MT-ND5 13637 13637 A G Q-R 30 MT-ND5 13730 13730 G A G-E 31 MT-ND6 14279 14279 G A S-L 32 MT-ND6 14325 14325 T C N-D 33 MT-ND6 14482 14482 C A M-I 34 MT-ND6 14482 14482 C G M-I 35 MT-ND6 14484 14484 T C M-V 36 MT-ND6 14495 14495 A G L-S 37 MT-ND6 14498 14498 T C Y-C 38 MT-ND6 14502 14502 T C I-V 39 MT-ND6 14568 14568 C T G-S 40 MT-
Discussion
The present study evaluated the distribution of mitochondrial genes and mutations among 275 Chinese LHON patients, in parallel with a control cohort of 281 subjects, using a multi-gene panel. Mutations of the multi-gene panel were designed from the Mitomap database, previous reports and our previous study in a Chinese Han population (8) (9) (10) . Twenty-seven amplicons, the specific primers for the point mutations, covered those of 46 mutations, as well as other substitutions in the amplicons, such as pathogenic mutations, m.3697G>A, m.10197G>A and m.14459G>A in the fragments of amplicon 4, 13 and 23, respectively. None of these three rare causative mutations were recorded among subjects in the test. Of the 46 mutations, the m.14727T>C variant in the MT-TE gene reported in encephalomyopathy patients (17) , was set as a negative control variant in the panel and was absent in all of the subjects. The panel with high-throughput sequencing makes it possible to screen multi-genes or multi-single nucleotide polymorphisms (SNPs) for subjects in a run, and provide more information than traditional Sanger sequencing. Certainly, sequencing the whole mtDNA genome is an optional selection using next generation sequencing. The information from the primary and secondary mutations may be indicative regarding the incomplete penetrance and other clinical symptoms.
It is generally accepted that LHON-associated mutations and their incidence are varied in populations with different ethnic backgrounds (18) . Consistent results were confirmed in our multi-gene panel screening. Twenty-three mutations in the panels were absent in the patients and control cohort in the current study. and 0.52. Of these, the incidence of m.3460G>A was markedly lower in this cohort than that in a Caucasian population reported by Mackey et al (24) . Additionally, the spectrum of secondary mutations associated with LHON was also dependent on their ethnic background, and were distinct between the Chinese and Caucasian cohorts. This panel screening demonstrated that the secondary mutations, m.12811T>C, m.11696G>A, m.3394T>C, m.3316G>A, m.14502T>C and m.12338T>C had higher frequencies in the patient cohort, as these mutations were assigned to Asian mtDNA lineage, including the macro-haplo group of M and N. Certainly, m.12811T>C is considered to be a polymorphic variant in sub-haplo groups of M7. While, mutations, m.3394T>C and m.11696G>A are categorized as haplo group-specific variants of M9a and D4j, respectively (25, 26) . Congruent results were obtained in our previous reports (27) .
Usually, secondary mutations, proposed to increase the penetrance of LHON (25) (26) (27) , are observed in LHON cases associated with m.11778G>A or m.14484T>C mutations. In the present study, 77.27% of variations of secondary mutations were coexistent with one of the primary mutations, m.11778G>A and m.14484T>C. Their detailed distribution was illustrated in Table V Table IV . Summary information of 46-point mutations in the cohort.
Primer mutations Incidence (%) Total
Patients The index number is according to Table I ; b 162 subjects carrying the m.11778G>A mutation, of which 60 subjects were carrying the m.11778G>A and one of the secondary variants; c 25 subjects carrying the m.14484T>C mutation, of which 8 subjects were carrying the m.14484T>C and a secondary variant. The three common mutations for LHON are emboldened. SNP, single nucleotide polymorphism.
Furthermore, more than one secondary mutation co-occurred with m.11778G>A, but not with m.14484T>C in this panel. m.3497C>T and m.3571C>T, which belong to the haplo group variants of B4c1, arose in three cases associated with m.11778G>A. In addition, m.9804G>A and m.14831G>A, reported as LHON-associated mutations in Caucasian cases, were common in the present control cohort according to the panel analysis. It was confirmed that the spectrum of mutations varied between ethnic backgrounds and indicated that the selected SNPs of the panel would be optimized for a Han population in the future.
In conclusion, the current data indicates that the spectrum and incidence of mtDNA mutation-associated LHON cases in the Han population are different to those in a Caucasian population. Here, the causative mutations associated with LHON, m.11778G>A, m.14484T>C, m.3460G>A, m.3635G>A, m.3866T>C and m.3733G>A, were observed in 70.55% of the patient cohort. The common secondary mutations in the Chinese LHON population were m.12811T>C, m.11696G>A, m.3394T>C, m.3316G>A, m.14502T>C and m.12338T>C. Furthermore, besides the three hotspots genes MT-ND1, MT-ND4 and MT-ND6, MT-ND5 also had a high incidence of secondary mutations including m.12811T>C and m.12338T>C; this finding was comparable with a previous study (29) . The primary and secondary mutation-associated LHON cases in the present multi-gene panel will advance current understanding of the clinical phenotype of LHON, and offer valuable information for the early diagnosis and subsequent options of intervention for mitigating risk of additional vision loss in LHON patients. 
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